NHBE cells infected with SARS-CoV-2 Analysis Results (GEO series: GSE147507)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
FOXM1
|
ENSG00000111206.8 | forkhead box M1 |
TBL1XR1
|
ENSG00000177565.11 | TBL1X receptor 1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
TBL1XR1 | hg19_v2_chr3_-_176914998_176915021 | 0.35 | 5.0e-01 | Click! |
FOXM1 | hg19_v2_chr12_-_2986107_2986258 | -0.33 | 5.3e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr19_+_56813305 | 2.51 |
ENST00000593151.1
|
AC006116.20
|
Uncharacterized protein |
chr1_-_179457805 | 1.89 |
ENST00000600581.1
|
AL160286.1
|
Uncharacterized protein |
chr4_-_85771168 | 1.78 |
ENST00000514071.1
|
WDFY3
|
WD repeat and FYVE domain containing 3 |
chr10_-_5652705 | 1.68 |
ENST00000425246.1
|
RP11-336A10.5
|
RP11-336A10.5 |
chr7_-_17598506 | 1.46 |
ENST00000451792.1
|
AC017060.1
|
AC017060.1 |
chr1_-_205391178 | 1.44 |
ENST00000367153.4
ENST00000367151.2 ENST00000391936.2 ENST00000367149.3 |
LEMD1
|
LEM domain containing 1 |
chr4_-_137842536 | 1.43 |
ENST00000512039.1
|
RP11-138I17.1
|
RP11-138I17.1 |
chr9_-_112970436 | 1.28 |
ENST00000400613.4
|
C9orf152
|
chromosome 9 open reading frame 152 |
chr12_-_8815299 | 1.21 |
ENST00000535336.1
|
MFAP5
|
microfibrillar associated protein 5 |
chr6_-_53530474 | 1.16 |
ENST00000370905.3
|
KLHL31
|
kelch-like family member 31 |
chr2_-_55496476 | 1.15 |
ENST00000441307.1
|
MTIF2
|
mitochondrial translational initiation factor 2 |
chr10_-_9801179 | 1.15 |
ENST00000419836.1
|
RP5-1051H14.2
|
RP5-1051H14.2 |
chr12_+_72058130 | 1.15 |
ENST00000547843.1
|
THAP2
|
THAP domain containing, apoptosis associated protein 2 |
chr19_-_35626104 | 1.11 |
ENST00000310123.3
ENST00000392225.3 |
LGI4
|
leucine-rich repeat LGI family, member 4 |
chr12_-_15038779 | 1.08 |
ENST00000228938.5
ENST00000539261.1 |
MGP
|
matrix Gla protein |
chr2_-_55496174 | 1.07 |
ENST00000417363.1
ENST00000412530.1 ENST00000394600.3 ENST00000366137.2 ENST00000420637.1 |
MTIF2
|
mitochondrial translational initiation factor 2 |
chr14_+_91709279 | 1.05 |
ENST00000554096.1
|
CTD-2547L24.3
|
HCG1816139; Uncharacterized protein |
chr4_-_140544386 | 1.05 |
ENST00000561977.1
|
RP11-308D13.3
|
RP11-308D13.3 |
chr19_-_54824344 | 1.04 |
ENST00000346508.3
ENST00000446712.3 ENST00000432233.3 ENST00000301219.3 |
LILRA5
|
leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 5 |
chr3_-_4927447 | 1.03 |
ENST00000449914.1
|
AC018816.3
|
Uncharacterized protein |
chr19_-_57967854 | 0.99 |
ENST00000321039.3
|
VN1R1
|
vomeronasal 1 receptor 1 |
chr5_-_179072047 | 0.99 |
ENST00000448248.2
|
C5orf60
|
chromosome 5 open reading frame 60 |
chr20_-_44333658 | 0.98 |
ENST00000330523.5
ENST00000335769.2 |
WFDC10B
|
WAP four-disulfide core domain 10B |
chr6_-_10694766 | 0.97 |
ENST00000460742.2
ENST00000259983.3 ENST00000379586.1 |
C6orf52
|
chromosome 6 open reading frame 52 |
chr10_-_106240032 | 0.95 |
ENST00000447860.1
|
RP11-127O4.3
|
RP11-127O4.3 |
chr12_-_8815404 | 0.93 |
ENST00000359478.2
ENST00000396549.2 |
MFAP5
|
microfibrillar associated protein 5 |
chr11_+_115498761 | 0.92 |
ENST00000424313.2
|
AP000997.1
|
AP000997.1 |
chr11_+_124824000 | 0.90 |
ENST00000529051.1
ENST00000344762.5 |
CCDC15
|
coiled-coil domain containing 15 |
chr1_+_212968025 | 0.90 |
ENST00000530399.2
|
TATDN3
|
TatD DNase domain containing 3 |
chr19_+_57742369 | 0.90 |
ENST00000415300.2
ENST00000448930.1 |
AURKC
|
aurora kinase C |
chr11_-_104817919 | 0.88 |
ENST00000533252.1
|
CASP4
|
caspase 4, apoptosis-related cysteine peptidase |
chr21_+_39628780 | 0.87 |
ENST00000417042.1
|
KCNJ15
|
potassium inwardly-rectifying channel, subfamily J, member 15 |
chr2_-_25451065 | 0.87 |
ENST00000606328.1
|
RP11-458N5.1
|
RP11-458N5.1 |
chr1_-_159880159 | 0.85 |
ENST00000599780.1
|
AL590560.1
|
HCG1995379; Uncharacterized protein |
chr11_+_29181503 | 0.81 |
ENST00000530960.1
|
RP11-466I1.1
|
RP11-466I1.1 |
chr11_+_64004888 | 0.81 |
ENST00000541681.1
|
VEGFB
|
vascular endothelial growth factor B |
chr1_+_152943122 | 0.80 |
ENST00000328051.2
|
SPRR4
|
small proline-rich protein 4 |
chr3_-_121467983 | 0.80 |
ENST00000472475.1
|
GOLGB1
|
golgin B1 |
chr12_-_85430024 | 0.80 |
ENST00000547836.1
ENST00000532498.2 |
TSPAN19
|
tetraspanin 19 |
chr6_+_31105426 | 0.78 |
ENST00000547221.1
|
PSORS1C1
|
psoriasis susceptibility 1 candidate 1 |
chr12_-_91573132 | 0.78 |
ENST00000550563.1
ENST00000546370.1 |
DCN
|
decorin |
chr1_+_48688357 | 0.78 |
ENST00000533824.1
ENST00000438567.2 ENST00000236495.5 ENST00000420136.2 |
SLC5A9
|
solute carrier family 5 (sodium/sugar cotransporter), member 9 |
chr19_-_35625765 | 0.78 |
ENST00000591633.1
|
LGI4
|
leucine-rich repeat LGI family, member 4 |
chr2_+_102608306 | 0.78 |
ENST00000332549.3
|
IL1R2
|
interleukin 1 receptor, type II |
chr7_-_99573677 | 0.77 |
ENST00000292401.4
|
AZGP1
|
alpha-2-glycoprotein 1, zinc-binding |
chr3_+_29323043 | 0.77 |
ENST00000452462.1
ENST00000456853.1 |
RBMS3
|
RNA binding motif, single stranded interacting protein 3 |
chr17_+_58018269 | 0.77 |
ENST00000591035.1
|
RP11-178C3.1
|
Uncharacterized protein |
chr18_+_74240756 | 0.77 |
ENST00000584910.1
ENST00000582452.1 |
LINC00908
|
long intergenic non-protein coding RNA 908 |
chr5_-_55008136 | 0.77 |
ENST00000503891.1
ENST00000507109.1 |
SLC38A9
|
solute carrier family 38, member 9 |
chr1_+_152758690 | 0.77 |
ENST00000368771.1
ENST00000368770.3 |
LCE1E
|
late cornified envelope 1E |
chr15_+_66585555 | 0.76 |
ENST00000319194.5
ENST00000525134.2 ENST00000441424.2 |
DIS3L
|
DIS3 mitotic control homolog (S. cerevisiae)-like |
chr2_-_26251481 | 0.75 |
ENST00000599234.1
|
AC013449.1
|
Uncharacterized protein |
chr16_-_3149278 | 0.75 |
ENST00000575108.1
ENST00000576483.1 ENST00000538082.2 ENST00000576985.1 |
ZSCAN10
|
zinc finger and SCAN domain containing 10 |
chr9_+_108424738 | 0.75 |
ENST00000334077.3
|
TAL2
|
T-cell acute lymphocytic leukemia 2 |
chr14_-_57197224 | 0.75 |
ENST00000554597.1
ENST00000556696.1 |
RP11-1085N6.3
|
Uncharacterized protein |
chr9_+_96928516 | 0.75 |
ENST00000602703.1
|
RP11-2B6.3
|
RP11-2B6.3 |
chr6_+_32605134 | 0.74 |
ENST00000343139.5
ENST00000395363.1 ENST00000496318.1 |
HLA-DQA1
|
major histocompatibility complex, class II, DQ alpha 1 |
chr11_-_104905840 | 0.74 |
ENST00000526568.1
ENST00000393136.4 ENST00000531166.1 ENST00000534497.1 ENST00000527979.1 ENST00000446369.1 ENST00000353247.5 ENST00000528974.1 ENST00000533400.1 ENST00000525825.1 ENST00000436863.3 |
CASP1
|
caspase 1, apoptosis-related cysteine peptidase |
chr10_-_14646388 | 0.73 |
ENST00000468747.1
ENST00000378467.4 |
FAM107B
|
family with sequence similarity 107, member B |
chr4_+_26859300 | 0.72 |
ENST00000494628.2
|
STIM2
|
stromal interaction molecule 2 |
chr11_-_111944895 | 0.72 |
ENST00000431456.1
ENST00000280350.4 ENST00000530641.1 |
PIH1D2
|
PIH1 domain containing 2 |
chr19_+_19976683 | 0.71 |
ENST00000592725.1
|
ZNF253
|
zinc finger protein 253 |
chr16_-_30032610 | 0.71 |
ENST00000574405.1
|
DOC2A
|
double C2-like domains, alpha |
chr4_+_175205100 | 0.71 |
ENST00000515299.1
|
CEP44
|
centrosomal protein 44kDa |
chr19_-_54106751 | 0.70 |
ENST00000600193.1
|
CTB-167G5.5
|
Uncharacterized protein |
chr7_+_141490017 | 0.70 |
ENST00000247883.4
|
TAS2R5
|
taste receptor, type 2, member 5 |
chr17_-_41277317 | 0.70 |
ENST00000497488.1
ENST00000489037.1 ENST00000470026.1 ENST00000586385.1 ENST00000591534.1 ENST00000591849.1 |
BRCA1
|
breast cancer 1, early onset |
chr1_-_17676070 | 0.70 |
ENST00000602074.1
|
AC004824.2
|
Uncharacterized protein |
chr11_+_62495541 | 0.70 |
ENST00000530625.1
ENST00000513247.2 |
TTC9C
|
tetratricopeptide repeat domain 9C |
chr12_-_66317967 | 0.69 |
ENST00000601398.1
|
AC090673.2
|
Uncharacterized protein |
chr4_+_26165074 | 0.69 |
ENST00000512351.1
|
RBPJ
|
recombination signal binding protein for immunoglobulin kappa J region |
chr7_-_107968999 | 0.68 |
ENST00000456431.1
|
NRCAM
|
neuronal cell adhesion molecule |
chr15_+_86098670 | 0.68 |
ENST00000558811.1
|
AKAP13
|
A kinase (PRKA) anchor protein 13 |
chrX_-_80457385 | 0.67 |
ENST00000451455.1
ENST00000436386.1 ENST00000358130.2 |
HMGN5
|
high mobility group nucleosome binding domain 5 |
chr12_+_27175476 | 0.67 |
ENST00000546323.1
ENST00000282892.3 |
MED21
|
mediator complex subunit 21 |
chr19_-_40596828 | 0.67 |
ENST00000414720.2
ENST00000455521.1 ENST00000340963.5 ENST00000595773.1 |
ZNF780A
|
zinc finger protein 780A |
chr1_+_109102652 | 0.66 |
ENST00000370035.3
ENST00000405454.1 |
FAM102B
|
family with sequence similarity 102, member B |
chr12_+_51317788 | 0.66 |
ENST00000550502.1
|
METTL7A
|
methyltransferase like 7A |
chr9_+_67968793 | 0.65 |
ENST00000417488.1
|
RP11-195B21.3
|
Protein LOC644249 |
chr1_+_160709055 | 0.65 |
ENST00000368043.3
ENST00000368042.3 ENST00000458602.2 ENST00000458104.2 |
SLAMF7
|
SLAM family member 7 |
chr1_+_170501270 | 0.65 |
ENST00000367763.3
ENST00000367762.1 |
GORAB
|
golgin, RAB6-interacting |
chr8_-_65730127 | 0.64 |
ENST00000522106.1
|
RP11-1D12.2
|
RP11-1D12.2 |
chr12_+_113344755 | 0.64 |
ENST00000550883.1
|
OAS1
|
2'-5'-oligoadenylate synthetase 1, 40/46kDa |
chr8_+_97773457 | 0.64 |
ENST00000521142.1
|
CPQ
|
carboxypeptidase Q |
chr19_+_54135310 | 0.64 |
ENST00000376650.1
|
DPRX
|
divergent-paired related homeobox |
chr5_+_79783788 | 0.63 |
ENST00000282226.4
|
FAM151B
|
family with sequence similarity 151, member B |
chr13_-_41345277 | 0.63 |
ENST00000323563.6
|
MRPS31
|
mitochondrial ribosomal protein S31 |
chr12_-_66035922 | 0.62 |
ENST00000546198.1
ENST00000535315.1 ENST00000537298.1 |
RP11-230G5.2
|
RP11-230G5.2 |
chr21_+_27011584 | 0.62 |
ENST00000400532.1
ENST00000480456.1 ENST00000312957.5 |
JAM2
|
junctional adhesion molecule 2 |
chr6_-_146057144 | 0.62 |
ENST00000367519.3
|
EPM2A
|
epilepsy, progressive myoclonus type 2A, Lafora disease (laforin) |
chr2_-_112237835 | 0.62 |
ENST00000442293.1
ENST00000439494.1 |
MIR4435-1HG
|
MIR4435-1 host gene (non-protein coding) |
chr17_-_41277370 | 0.62 |
ENST00000476777.1
ENST00000491747.2 ENST00000478531.1 ENST00000477152.1 ENST00000357654.3 ENST00000493795.1 ENST00000493919.1 |
BRCA1
|
breast cancer 1, early onset |
chr3_+_172034218 | 0.62 |
ENST00000366261.2
|
AC092964.1
|
Uncharacterized protein |
chr3_-_42003613 | 0.61 |
ENST00000414606.1
|
ULK4
|
unc-51 like kinase 4 |
chr10_-_10836919 | 0.61 |
ENST00000602763.1
ENST00000415590.2 ENST00000434919.2 |
SFTA1P
|
surfactant associated 1, pseudogene |
chr17_-_36997708 | 0.61 |
ENST00000398575.4
|
C17orf98
|
chromosome 17 open reading frame 98 |
chr19_+_42381173 | 0.61 |
ENST00000221972.3
|
CD79A
|
CD79a molecule, immunoglobulin-associated alpha |
chr12_+_105724613 | 0.61 |
ENST00000549934.2
|
C12orf75
|
chromosome 12 open reading frame 75 |
chr3_+_29322437 | 0.61 |
ENST00000434693.2
|
RBMS3
|
RNA binding motif, single stranded interacting protein 3 |
chr1_+_207039154 | 0.61 |
ENST00000367096.3
ENST00000391930.2 |
IL20
|
interleukin 20 |
chr7_-_110174754 | 0.60 |
ENST00000435466.1
|
AC003088.1
|
AC003088.1 |
chr10_+_88780049 | 0.60 |
ENST00000343959.4
|
FAM25A
|
family with sequence similarity 25, member A |
chr11_+_5646213 | 0.60 |
ENST00000429814.2
|
TRIM34
|
tripartite motif containing 34 |
chr2_+_102928009 | 0.60 |
ENST00000404917.2
ENST00000447231.1 |
IL1RL1
|
interleukin 1 receptor-like 1 |
chr1_-_235098861 | 0.60 |
ENST00000458044.1
|
RP11-443B7.1
|
RP11-443B7.1 |
chr14_-_36645674 | 0.60 |
ENST00000556013.2
|
PTCSC3
|
papillary thyroid carcinoma susceptibility candidate 3 (non-protein coding) |
chr5_+_172571445 | 0.60 |
ENST00000231668.9
ENST00000351486.5 ENST00000352523.6 ENST00000393770.4 |
BNIP1
|
BCL2/adenovirus E1B 19kDa interacting protein 1 |
chr12_+_6933660 | 0.59 |
ENST00000545321.1
|
GPR162
|
G protein-coupled receptor 162 |
chr12_-_123717711 | 0.59 |
ENST00000537854.1
|
MPHOSPH9
|
M-phase phosphoprotein 9 |
chr2_-_61389168 | 0.59 |
ENST00000607743.1
ENST00000605902.1 |
RP11-493E12.1
|
RP11-493E12.1 |
chr6_-_10435032 | 0.59 |
ENST00000491317.1
ENST00000496285.1 ENST00000479822.1 ENST00000487130.1 |
LINC00518
|
long intergenic non-protein coding RNA 518 |
chr1_-_224216371 | 0.59 |
ENST00000600307.1
|
AC138393.1
|
Uncharacterized protein |
chr7_+_111846643 | 0.58 |
ENST00000361822.3
|
ZNF277
|
zinc finger protein 277 |
chrX_-_153141783 | 0.58 |
ENST00000458029.1
|
L1CAM
|
L1 cell adhesion molecule |
chr1_+_161677034 | 0.58 |
ENST00000349527.4
ENST00000309691.6 ENST00000294796.4 ENST00000367953.3 ENST00000367950.1 |
FCRLA
|
Fc receptor-like A |
chr4_-_140527848 | 0.58 |
ENST00000608795.1
ENST00000608958.1 |
SETD7
|
SET domain containing (lysine methyltransferase) 7 |
chr11_-_34533257 | 0.58 |
ENST00000312319.2
|
ELF5
|
E74-like factor 5 (ets domain transcription factor) |
chr11_-_111383064 | 0.58 |
ENST00000525791.1
ENST00000456861.2 ENST00000356018.2 |
BTG4
|
B-cell translocation gene 4 |
chr3_+_42642211 | 0.58 |
ENST00000442970.1
ENST00000445842.1 |
NKTR
|
natural killer-tumor recognition sequence |
chr19_-_40596767 | 0.58 |
ENST00000599972.1
ENST00000450241.2 ENST00000595687.2 |
ZNF780A
|
zinc finger protein 780A |
chr6_+_163837347 | 0.57 |
ENST00000544436.1
|
QKI
|
QKI, KH domain containing, RNA binding |
chr12_+_116997186 | 0.57 |
ENST00000306985.4
|
MAP1LC3B2
|
microtubule-associated protein 1 light chain 3 beta 2 |
chr7_-_32931623 | 0.57 |
ENST00000452926.1
|
KBTBD2
|
kelch repeat and BTB (POZ) domain containing 2 |
chr17_+_53016208 | 0.57 |
ENST00000574318.1
|
TOM1L1
|
target of myb1 (chicken)-like 1 |
chrX_+_102024075 | 0.57 |
ENST00000431616.1
ENST00000440496.1 ENST00000420471.1 ENST00000435966.1 |
LINC00630
|
long intergenic non-protein coding RNA 630 |
chr19_+_57742431 | 0.57 |
ENST00000302804.7
|
AURKC
|
aurora kinase C |
chr19_+_39786962 | 0.57 |
ENST00000333625.2
|
IFNL1
|
interferon, lambda 1 |
chr4_+_165675197 | 0.56 |
ENST00000515485.1
|
RP11-294O2.2
|
RP11-294O2.2 |
chr17_-_72968837 | 0.55 |
ENST00000581676.1
|
HID1
|
HID1 domain containing |
chr4_+_89300158 | 0.55 |
ENST00000502870.1
|
HERC6
|
HECT and RLD domain containing E3 ubiquitin protein ligase family member 6 |
chr10_+_67330096 | 0.55 |
ENST00000433152.4
ENST00000601979.1 ENST00000599409.1 ENST00000608678.1 |
RP11-222A11.1
|
RP11-222A11.1 |
chr4_+_154073469 | 0.55 |
ENST00000441616.1
|
TRIM2
|
tripartite motif containing 2 |
chr8_+_38586068 | 0.55 |
ENST00000443286.2
ENST00000520340.1 ENST00000518415.1 |
TACC1
|
transforming, acidic coiled-coil containing protein 1 |
chr15_+_59903975 | 0.55 |
ENST00000560585.1
ENST00000396065.1 |
GCNT3
|
glucosaminyl (N-acetyl) transferase 3, mucin type |
chr6_+_27215471 | 0.55 |
ENST00000421826.2
|
PRSS16
|
protease, serine, 16 (thymus) |
chr4_+_175205038 | 0.54 |
ENST00000457424.2
ENST00000514712.1 |
CEP44
|
centrosomal protein 44kDa |
chr1_+_248031277 | 0.54 |
ENST00000537741.1
|
OR2W3
|
olfactory receptor, family 2, subfamily W, member 3 |
chr2_+_232316906 | 0.54 |
ENST00000370380.2
|
AC017104.2
|
Uncharacterized protein |
chr3_+_121289551 | 0.54 |
ENST00000334384.3
|
ARGFX
|
arginine-fifty homeobox |
chr14_+_66578299 | 0.54 |
ENST00000554187.1
ENST00000556662.1 ENST00000556291.1 ENST00000557723.1 ENST00000557050.1 |
RP11-783L4.1
|
RP11-783L4.1 |
chr12_+_34175398 | 0.54 |
ENST00000538927.1
|
ALG10
|
ALG10, alpha-1,2-glucosyltransferase |
chr19_+_35417939 | 0.54 |
ENST00000601142.1
ENST00000426813.2 |
ZNF30
|
zinc finger protein 30 |
chr17_-_41465674 | 0.53 |
ENST00000592135.1
ENST00000587874.1 ENST00000588654.1 ENST00000592094.1 |
LINC00910
|
long intergenic non-protein coding RNA 910 |
chr5_+_96424779 | 0.53 |
ENST00000509481.1
|
CTD-2215E18.1
|
Uncharacterized protein |
chr17_-_47045949 | 0.53 |
ENST00000357424.2
|
GIP
|
gastric inhibitory polypeptide |
chr12_-_24737089 | 0.53 |
ENST00000483544.1
|
LINC00477
|
long intergenic non-protein coding RNA 477 |
chr6_-_121655850 | 0.53 |
ENST00000422369.1
|
TBC1D32
|
TBC1 domain family, member 32 |
chr10_-_96829246 | 0.53 |
ENST00000371270.3
ENST00000535898.1 ENST00000539050.1 |
CYP2C8
|
cytochrome P450, family 2, subfamily C, polypeptide 8 |
chr2_+_231090433 | 0.52 |
ENST00000486687.2
ENST00000350136.5 ENST00000392045.3 ENST00000417495.3 ENST00000343805.6 ENST00000420434.3 |
SP140
|
SP140 nuclear body protein |
chr1_+_112016414 | 0.52 |
ENST00000343534.5
ENST00000369718.3 |
C1orf162
|
chromosome 1 open reading frame 162 |
chr5_-_146833803 | 0.52 |
ENST00000512722.1
|
DPYSL3
|
dihydropyrimidinase-like 3 |
chr17_+_67498396 | 0.52 |
ENST00000588110.1
|
MAP2K6
|
mitogen-activated protein kinase kinase 6 |
chr4_+_175205162 | 0.52 |
ENST00000503053.1
|
CEP44
|
centrosomal protein 44kDa |
chr19_-_57656570 | 0.52 |
ENST00000269834.1
|
ZIM3
|
zinc finger, imprinted 3 |
chr20_+_55099542 | 0.51 |
ENST00000371328.3
|
FAM209A
|
family with sequence similarity 209, member A |
chr3_+_42897512 | 0.51 |
ENST00000493193.1
|
ACKR2
|
atypical chemokine receptor 2 |
chr7_+_142448053 | 0.51 |
ENST00000422143.2
|
TRBV29-1
|
T cell receptor beta variable 29-1 |
chr14_+_22591276 | 0.51 |
ENST00000390455.3
|
TRAV26-1
|
T cell receptor alpha variable 26-1 |
chr15_-_82555000 | 0.51 |
ENST00000557844.1
ENST00000359445.3 ENST00000268206.7 |
EFTUD1
|
elongation factor Tu GTP binding domain containing 1 |
chr2_-_169769787 | 0.51 |
ENST00000451987.1
|
SPC25
|
SPC25, NDC80 kinetochore complex component |
chr2_+_152214098 | 0.51 |
ENST00000243347.3
|
TNFAIP6
|
tumor necrosis factor, alpha-induced protein 6 |
chr11_-_125932685 | 0.51 |
ENST00000527967.1
|
CDON
|
cell adhesion associated, oncogene regulated |
chr5_+_142286887 | 0.51 |
ENST00000451259.1
|
ARHGAP26
|
Rho GTPase activating protein 26 |
chr6_+_35996859 | 0.51 |
ENST00000472333.1
|
MAPK14
|
mitogen-activated protein kinase 14 |
chr17_-_47786375 | 0.50 |
ENST00000511657.1
|
SLC35B1
|
solute carrier family 35, member B1 |
chr2_+_114163945 | 0.50 |
ENST00000453673.3
|
IGKV1OR2-108
|
immunoglobulin kappa variable 1/OR2-108 (non-functional) |
chr7_-_25219667 | 0.50 |
ENST00000444434.1
|
C7orf31
|
chromosome 7 open reading frame 31 |
chr8_+_101349823 | 0.50 |
ENST00000519566.1
|
KB-1991G8.1
|
KB-1991G8.1 |
chr18_+_44812072 | 0.50 |
ENST00000598649.1
ENST00000586905.2 |
CTD-2130O13.1
|
CTD-2130O13.1 |
chr17_-_41277467 | 0.50 |
ENST00000494123.1
ENST00000346315.3 ENST00000309486.4 ENST00000468300.1 ENST00000354071.3 ENST00000352993.3 ENST00000471181.2 |
BRCA1
|
breast cancer 1, early onset |
chr9_+_5510558 | 0.50 |
ENST00000397747.3
|
PDCD1LG2
|
programmed cell death 1 ligand 2 |
chr6_-_125623046 | 0.49 |
ENST00000608295.1
ENST00000398153.2 ENST00000608284.1 ENST00000368377.4 |
HDDC2
|
HD domain containing 2 |
chr1_+_59486059 | 0.49 |
ENST00000447329.1
|
RP4-794H19.4
|
RP4-794H19.4 |
chr7_+_23210760 | 0.49 |
ENST00000366347.4
|
AC005082.1
|
Uncharacterized protein |
chr7_+_56019486 | 0.49 |
ENST00000446692.1
ENST00000285298.4 ENST00000443449.1 |
GBAS
MRPS17
|
glioblastoma amplified sequence mitochondrial ribosomal protein S17 |
chr3_-_172312460 | 0.49 |
ENST00000418839.2
|
RP11-408H1.3
|
RP11-408H1.3 |
chr20_+_31823091 | 0.49 |
ENST00000601172.1
|
AL121901.1
|
Nasopharyngeal carcinoma-related protein YH1; Uncharacterized protein |
chr20_-_56195525 | 0.49 |
ENST00000371173.3
ENST00000395822.3 ENST00000340462.4 ENST00000343535.4 |
ZBP1
|
Z-DNA binding protein 1 |
chrX_-_16730688 | 0.49 |
ENST00000359276.4
|
CTPS2
|
CTP synthase 2 |
chr1_-_52520828 | 0.49 |
ENST00000610127.1
|
TXNDC12
|
thioredoxin domain containing 12 (endoplasmic reticulum) |
chr16_-_50402690 | 0.48 |
ENST00000394689.2
|
BRD7
|
bromodomain containing 7 |
chr9_+_74526532 | 0.48 |
ENST00000486911.2
|
C9orf85
|
chromosome 9 open reading frame 85 |
chr8_+_97506033 | 0.48 |
ENST00000518385.1
|
SDC2
|
syndecan 2 |
chr14_+_24674926 | 0.48 |
ENST00000339917.5
ENST00000556621.1 ENST00000287913.6 ENST00000428351.2 ENST00000555092.1 |
TSSK4
|
testis-specific serine kinase 4 |
chr16_+_84801852 | 0.48 |
ENST00000569925.1
ENST00000567526.1 |
USP10
|
ubiquitin specific peptidase 10 |
chrX_+_80457442 | 0.48 |
ENST00000373212.5
|
SH3BGRL
|
SH3 domain binding glutamic acid-rich protein like |
chr10_-_22292675 | 0.48 |
ENST00000376946.1
|
DNAJC1
|
DnaJ (Hsp40) homolog, subfamily C, member 1 |
chr16_-_66907139 | 0.48 |
ENST00000561579.2
|
NAE1
|
NEDD8 activating enzyme E1 subunit 1 |
chr7_+_30185406 | 0.48 |
ENST00000324489.5
|
C7orf41
|
maturin, neural progenitor differentiation regulator homolog (Xenopus) |
chr7_+_116660246 | 0.48 |
ENST00000434836.1
ENST00000393443.1 ENST00000465133.1 ENST00000477742.1 ENST00000393447.4 ENST00000393444.3 |
ST7
|
suppression of tumorigenicity 7 |
chr22_+_39436862 | 0.48 |
ENST00000381565.2
ENST00000452957.2 |
APOBEC3F
APOBEC3G
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3F apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G |
chr5_-_55008101 | 0.48 |
ENST00000506624.1
ENST00000513275.1 ENST00000513993.1 |
SLC38A9
|
solute carrier family 38, member 9 |
chr20_-_45142154 | 0.48 |
ENST00000347606.4
ENST00000457685.2 |
ZNF334
|
zinc finger protein 334 |
chr2_+_9615179 | 0.48 |
ENST00000495797.1
|
IAH1
|
isoamyl acetate-hydrolyzing esterase 1 homolog (S. cerevisiae) |
chr9_+_42704004 | 0.48 |
ENST00000457288.1
|
CBWD7
|
COBW domain containing 7 |
chr19_-_53426700 | 0.48 |
ENST00000596623.1
|
ZNF888
|
zinc finger protein 888 |
chr3_+_132036243 | 0.48 |
ENST00000475741.1
ENST00000351273.7 |
ACPP
|
acid phosphatase, prostate |
chr5_-_43397184 | 0.48 |
ENST00000513525.1
|
CCL28
|
chemokine (C-C motif) ligand 28 |
chr19_-_40562063 | 0.48 |
ENST00000598845.1
ENST00000593605.1 ENST00000221355.6 ENST00000434248.1 |
ZNF780B
|
zinc finger protein 780B |
chr3_+_42885450 | 0.47 |
ENST00000492609.1
|
ACKR2
|
atypical chemokine receptor 2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 1.8 | GO:0070512 | regulation of histone H4-K20 methylation(GO:0070510) positive regulation of histone H4-K20 methylation(GO:0070512) |
0.5 | 2.5 | GO:0070124 | mitochondrial translational initiation(GO:0070124) |
0.3 | 0.8 | GO:0060168 | positive regulation of adenosine receptor signaling pathway(GO:0060168) |
0.2 | 1.0 | GO:0050712 | negative regulation of interleukin-1 alpha production(GO:0032690) negative regulation of interleukin-1 alpha secretion(GO:0050712) |
0.2 | 1.2 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
0.2 | 0.2 | GO:0030575 | nuclear body organization(GO:0030575) |
0.2 | 0.2 | GO:1904933 | regulation of cell proliferation in midbrain(GO:1904933) |
0.2 | 0.6 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.2 | 0.8 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.2 | 0.6 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) sesquiterpenoid catabolic process(GO:0016107) farnesol metabolic process(GO:0016487) farnesol catabolic process(GO:0016488) |
0.2 | 0.6 | GO:0034130 | toll-like receptor 1 signaling pathway(GO:0034130) |
0.2 | 0.6 | GO:0046022 | positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
0.2 | 1.2 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
0.2 | 1.0 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
0.2 | 0.8 | GO:0050705 | regulation of interleukin-1 alpha secretion(GO:0050705) positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.2 | 0.6 | GO:0046356 | acetyl-CoA catabolic process(GO:0046356) |
0.2 | 0.6 | GO:0061394 | regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance(GO:0061394) |
0.2 | 0.6 | GO:0071449 | cellular response to lipid hydroperoxide(GO:0071449) |
0.2 | 0.6 | GO:0061567 | dADP phosphorylation(GO:0006174) dGDP phosphorylation(GO:0006186) AMP phosphorylation(GO:0006756) CDP phosphorylation(GO:0061508) dAMP phosphorylation(GO:0061565) CMP phosphorylation(GO:0061566) dCMP phosphorylation(GO:0061567) GDP phosphorylation(GO:0061568) UDP phosphorylation(GO:0061569) dCDP phosphorylation(GO:0061570) TDP phosphorylation(GO:0061571) |
0.2 | 0.5 | GO:0033685 | negative regulation of luteinizing hormone secretion(GO:0033685) |
0.2 | 2.0 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
0.2 | 0.7 | GO:0019521 | aldonic acid metabolic process(GO:0019520) D-gluconate metabolic process(GO:0019521) |
0.2 | 0.9 | GO:0043686 | co-translational protein modification(GO:0043686) |
0.2 | 0.5 | GO:1904784 | NLRP1 inflammasome complex assembly(GO:1904784) |
0.2 | 0.5 | GO:0046709 | IDP metabolic process(GO:0046707) IDP catabolic process(GO:0046709) |
0.2 | 0.9 | GO:0070980 | biphenyl catabolic process(GO:0070980) |
0.2 | 0.5 | GO:0002877 | acute inflammatory response to non-antigenic stimulus(GO:0002525) regulation of acute inflammatory response to non-antigenic stimulus(GO:0002877) |
0.2 | 1.0 | GO:0019236 | response to pheromone(GO:0019236) |
0.2 | 0.7 | GO:2000298 | regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
0.2 | 0.5 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
0.2 | 1.0 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
0.2 | 0.5 | GO:0002276 | basophil activation involved in immune response(GO:0002276) basophil activation(GO:0045575) |
0.2 | 0.5 | GO:0042214 | terpene metabolic process(GO:0042214) |
0.2 | 0.5 | GO:0036146 | cellular response to mycotoxin(GO:0036146) |
0.2 | 1.0 | GO:0002784 | antimicrobial peptide production(GO:0002775) antibacterial peptide production(GO:0002778) regulation of antimicrobial peptide production(GO:0002784) regulation of antibacterial peptide production(GO:0002786) |
0.2 | 2.1 | GO:0035973 | aggrephagy(GO:0035973) |
0.2 | 0.3 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.2 | 0.6 | GO:0046110 | xanthine metabolic process(GO:0046110) |
0.2 | 0.5 | GO:0036451 | cap mRNA methylation(GO:0036451) |
0.1 | 0.3 | GO:0090235 | regulation of metaphase plate congression(GO:0090235) |
0.1 | 0.4 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.1 | 0.4 | GO:1902214 | regulation of interleukin-4-mediated signaling pathway(GO:1902214) |
0.1 | 0.1 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
0.1 | 0.1 | GO:0010430 | fatty acid omega-oxidation(GO:0010430) |
0.1 | 0.3 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
0.1 | 1.2 | GO:1905068 | positive regulation of ephrin receptor signaling pathway(GO:1901189) positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:1901297) positive regulation of canonical Wnt signaling pathway involved in heart development(GO:1905068) |
0.1 | 0.6 | GO:0072334 | UDP-galactose transport(GO:0015785) UDP-galactose transmembrane transport(GO:0072334) |
0.1 | 0.1 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.1 | 0.1 | GO:0010039 | response to iron ion(GO:0010039) |
0.1 | 0.6 | GO:0009236 | cobalamin biosynthetic process(GO:0009236) |
0.1 | 0.6 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
0.1 | 0.1 | GO:0071354 | cellular response to interleukin-6(GO:0071354) |
0.1 | 1.1 | GO:0052697 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
0.1 | 0.7 | GO:0046086 | adenosine biosynthetic process(GO:0046086) |
0.1 | 0.4 | GO:0033341 | regulation of collagen binding(GO:0033341) |
0.1 | 0.4 | GO:1904896 | ESCRT complex disassembly(GO:1904896) ESCRT III complex disassembly(GO:1904903) |
0.1 | 0.5 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.1 | 0.4 | GO:1903251 | multi-ciliated epithelial cell differentiation(GO:1903251) |
0.1 | 0.7 | GO:0039507 | modulation by virus of host molecular function(GO:0039506) suppression by virus of host molecular function(GO:0039507) suppression by virus of host catalytic activity(GO:0039513) modulation by virus of host catalytic activity(GO:0039516) suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process(GO:0039650) negative regulation by symbiont of host catalytic activity(GO:0052053) negative regulation by symbiont of host molecular function(GO:0052056) modulation by symbiont of host catalytic activity(GO:0052148) |
0.1 | 0.1 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.1 | 0.4 | GO:1903595 | positive regulation of histamine secretion by mast cell(GO:1903595) |
0.1 | 0.4 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
0.1 | 0.7 | GO:0050851 | antigen receptor-mediated signaling pathway(GO:0050851) |
0.1 | 0.5 | GO:0036292 | DNA rewinding(GO:0036292) |
0.1 | 0.5 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.1 | 1.3 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.1 | 0.9 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.1 | 0.5 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.1 | 0.1 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.1 | 0.9 | GO:0002933 | lipid hydroxylation(GO:0002933) |
0.1 | 0.9 | GO:0008218 | bioluminescence(GO:0008218) |
0.1 | 0.1 | GO:1901216 | positive regulation of neuron death(GO:1901216) |
0.1 | 1.4 | GO:2000002 | negative regulation of DNA damage checkpoint(GO:2000002) |
0.1 | 0.1 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.1 | 0.4 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
0.1 | 0.9 | GO:0038172 | interleukin-33-mediated signaling pathway(GO:0038172) |
0.1 | 0.4 | GO:0015993 | molecular hydrogen transport(GO:0015993) |
0.1 | 0.1 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
0.1 | 0.4 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.1 | 0.5 | GO:0052364 | multi-organism catabolic process(GO:0044035) development of symbiont involved in interaction with host(GO:0044115) modulation of development of symbiont involved in interaction with host(GO:0044145) negative regulation of development of symbiont involved in interaction with host(GO:0044147) metabolism of substance in other organism involved in symbiotic interaction(GO:0052214) catabolism of substance in other organism involved in symbiotic interaction(GO:0052227) metabolism of macromolecule in other organism involved in symbiotic interaction(GO:0052229) catabolism by host of symbiont macromolecule(GO:0052360) catabolism by organism of macromolecule in other organism involved in symbiotic interaction(GO:0052361) catabolism by host of symbiont protein(GO:0052362) catabolism by organism of protein in other organism involved in symbiotic interaction(GO:0052363) catabolism by host of substance in symbiont(GO:0052364) metabolism by host of symbiont macromolecule(GO:0052416) metabolism by host of symbiont protein(GO:0052417) metabolism by organism of protein in other organism involved in symbiotic interaction(GO:0052418) metabolism by host of substance in symbiont(GO:0052419) |
0.1 | 0.4 | GO:2000588 | positive regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000588) |
0.1 | 0.4 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.1 | 1.0 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
0.1 | 2.2 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.1 | 1.4 | GO:1903943 | regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
0.1 | 0.5 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.1 | 0.3 | GO:0061582 | intestinal epithelial cell migration(GO:0061582) |
0.1 | 0.7 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
0.1 | 0.9 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.1 | 0.1 | GO:0035878 | nail development(GO:0035878) |
0.1 | 0.7 | GO:0019542 | acetate biosynthetic process(GO:0019413) acetyl-CoA biosynthetic process from acetate(GO:0019427) propionate metabolic process(GO:0019541) propionate biosynthetic process(GO:0019542) |
0.1 | 1.0 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
0.1 | 0.8 | GO:0042100 | B cell proliferation(GO:0042100) |
0.1 | 0.6 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.1 | 0.1 | GO:2000645 | negative regulation of receptor catabolic process(GO:2000645) |
0.1 | 0.3 | GO:0009820 | alkaloid metabolic process(GO:0009820) |
0.1 | 0.3 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
0.1 | 0.8 | GO:1902896 | terminal web assembly(GO:1902896) |
0.1 | 0.3 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.1 | 0.4 | GO:1903542 | negative regulation of exosomal secretion(GO:1903542) |
0.1 | 0.6 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.1 | 0.3 | GO:0061300 | cerebellum vasculature development(GO:0061300) |
0.1 | 0.3 | GO:0036466 | synaptic vesicle recycling via endosome(GO:0036466) |
0.1 | 0.6 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.1 | 0.4 | GO:0030450 | regulation of complement activation, classical pathway(GO:0030450) negative regulation of complement activation, classical pathway(GO:0045959) |
0.1 | 0.6 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.1 | 0.5 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
0.1 | 0.2 | GO:0040012 | regulation of locomotion(GO:0040012) |
0.1 | 0.3 | GO:0071163 | DNA replication preinitiation complex assembly(GO:0071163) |
0.1 | 0.1 | GO:0019858 | cytosine metabolic process(GO:0019858) |
0.1 | 0.3 | GO:1904170 | septin ring assembly(GO:0000921) septin ring organization(GO:0031106) regulation of bleb assembly(GO:1904170) positive regulation of bleb assembly(GO:1904172) |
0.1 | 0.4 | GO:0002725 | negative regulation of T cell cytokine production(GO:0002725) |
0.1 | 0.2 | GO:0050787 | detoxification of mercury ion(GO:0050787) |
0.1 | 0.9 | GO:0034661 | rRNA catabolic process(GO:0016075) ncRNA catabolic process(GO:0034661) |
0.1 | 0.3 | GO:1902871 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) cerebral cortex GABAergic interneuron fate commitment(GO:0021893) positive regulation of neural retina development(GO:0061075) positive regulation of retina development in camera-type eye(GO:1902868) positive regulation of amacrine cell differentiation(GO:1902871) |
0.1 | 0.4 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.1 | 0.3 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.1 | 0.3 | GO:2001247 | positive regulation of phosphatidylcholine biosynthetic process(GO:2001247) |
0.1 | 0.3 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.1 | 0.2 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.1 | 0.6 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.1 | 1.1 | GO:0001554 | luteolysis(GO:0001554) |
0.1 | 0.4 | GO:1900034 | regulation of cellular response to heat(GO:1900034) |
0.1 | 1.0 | GO:2000373 | regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000371) positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000373) |
0.1 | 0.3 | GO:0018963 | insecticide metabolic process(GO:0017143) dibenzo-p-dioxin metabolic process(GO:0018894) phthalate metabolic process(GO:0018963) |
0.1 | 0.5 | GO:0070092 | regulation of glucagon secretion(GO:0070092) |
0.1 | 0.5 | GO:0045337 | geranyl diphosphate metabolic process(GO:0033383) geranyl diphosphate biosynthetic process(GO:0033384) farnesyl diphosphate biosynthetic process(GO:0045337) |
0.1 | 0.4 | GO:2000570 | T-helper 2 cell activation(GO:0035712) regulation of T-helper 2 cell activation(GO:2000569) positive regulation of T-helper 2 cell activation(GO:2000570) |
0.1 | 0.6 | GO:2000234 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
0.1 | 0.4 | GO:0048698 | negative regulation of collateral sprouting in absence of injury(GO:0048698) |
0.1 | 0.5 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
0.1 | 0.5 | GO:0097327 | response to antineoplastic agent(GO:0097327) |
0.1 | 0.3 | GO:0034402 | recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex(GO:0034402) |
0.1 | 0.8 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.1 | 0.3 | GO:1904562 | phosphatidylinositol 5-phosphate metabolic process(GO:1904562) |
0.1 | 0.4 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.1 | 0.5 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.1 | 1.7 | GO:0051256 | mitotic spindle midzone assembly(GO:0051256) |
0.1 | 0.4 | GO:0051255 | spindle midzone assembly(GO:0051255) |
0.1 | 0.5 | GO:0071503 | response to heparin(GO:0071503) cellular response to heparin(GO:0071504) |
0.1 | 0.2 | GO:0034627 | 'de novo' NAD biosynthetic process(GO:0034627) |
0.1 | 0.7 | GO:1905150 | regulation of voltage-gated sodium channel activity(GO:1905150) |
0.1 | 0.3 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.1 | 0.3 | GO:0003050 | regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
0.1 | 0.4 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.1 | 0.2 | GO:2001162 | regulation of histone H3-K79 methylation(GO:2001160) positive regulation of histone H3-K79 methylation(GO:2001162) |
0.1 | 1.1 | GO:2000582 | positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
0.1 | 0.3 | GO:0006617 | SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition(GO:0006617) |
0.1 | 0.4 | GO:0015783 | GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
0.1 | 0.1 | GO:0046619 | optic placode formation involved in camera-type eye formation(GO:0046619) |
0.1 | 0.1 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
0.1 | 0.3 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.1 | 0.3 | GO:0031662 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031660) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031662) response to DDT(GO:0046680) histone H3-S10 phosphorylation involved in chromosome condensation(GO:2000775) |
0.1 | 1.2 | GO:0046654 | tetrahydrofolate biosynthetic process(GO:0046654) |
0.1 | 0.6 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.1 | 0.1 | GO:0031627 | telomeric loop formation(GO:0031627) |
0.1 | 0.1 | GO:0019405 | alditol catabolic process(GO:0019405) |
0.1 | 0.2 | GO:0030185 | nitric oxide transport(GO:0030185) |
0.1 | 0.7 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
0.1 | 0.1 | GO:0009405 | pathogenesis(GO:0009405) |
0.1 | 0.3 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
0.1 | 1.5 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.1 | 0.4 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.1 | 0.6 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.1 | 0.2 | GO:1902299 | pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
0.1 | 0.6 | GO:0045204 | MAPK export from nucleus(GO:0045204) |
0.1 | 0.1 | GO:0019731 | antibacterial humoral response(GO:0019731) |
0.1 | 0.2 | GO:1901656 | glycoside transport(GO:1901656) |
0.1 | 0.2 | GO:0051066 | dihydrobiopterin metabolic process(GO:0051066) |
0.1 | 0.3 | GO:0050925 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) chemorepulsion involved in postnatal olfactory bulb interneuron migration(GO:0021836) negative regulation of negative chemotaxis(GO:0050925) |
0.1 | 0.3 | GO:0034473 | U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) |
0.1 | 0.1 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.1 | 0.3 | GO:0010652 | regulation of cell communication by chemical coupling(GO:0010645) positive regulation of cell communication by chemical coupling(GO:0010652) |
0.1 | 0.4 | GO:0018126 | protein hydroxylation(GO:0018126) |
0.1 | 0.2 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.1 | 0.2 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
0.1 | 0.9 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.1 | 0.6 | GO:0030207 | chondroitin sulfate catabolic process(GO:0030207) |
0.1 | 0.4 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
0.1 | 0.2 | GO:0038109 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.1 | 0.2 | GO:2000625 | regulation of miRNA catabolic process(GO:2000625) positive regulation of miRNA catabolic process(GO:2000627) |
0.1 | 0.8 | GO:0055048 | regulation of spindle elongation(GO:0032887) regulation of mitotic spindle elongation(GO:0032888) anastral spindle assembly(GO:0055048) protein localization to spindle pole body(GO:0071988) regulation of protein localization to spindle pole body(GO:1902363) positive regulation of protein localization to spindle pole body(GO:1902365) positive regulation of mitotic spindle elongation(GO:1902846) |
0.1 | 0.1 | GO:0035106 | operant conditioning(GO:0035106) |
0.1 | 0.5 | GO:0051305 | mitotic chromosome movement towards spindle pole(GO:0007079) chromosome movement towards spindle pole(GO:0051305) |
0.1 | 0.3 | GO:0042144 | vacuole fusion, non-autophagic(GO:0042144) |
0.1 | 0.2 | GO:1903778 | protein localization to vacuolar membrane(GO:1903778) |
0.1 | 1.7 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.1 | 0.2 | GO:0070668 | mast cell proliferation(GO:0070662) regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
0.1 | 0.5 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
0.1 | 0.4 | GO:0018057 | peptidyl-lysine oxidation(GO:0018057) |
0.1 | 0.2 | GO:0022615 | protein to membrane docking(GO:0022615) |
0.1 | 0.3 | GO:0022614 | membrane to membrane docking(GO:0022614) |
0.1 | 0.6 | GO:0015793 | glycerol transport(GO:0015793) |
0.1 | 0.4 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.1 | 2.2 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.1 | 0.4 | GO:0035063 | nuclear speck organization(GO:0035063) |
0.1 | 0.1 | GO:0032425 | positive regulation of mismatch repair(GO:0032425) |
0.1 | 1.0 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.1 | 0.1 | GO:1903298 | regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) intrinsic apoptotic signaling pathway in response to hypoxia(GO:1990144) |
0.1 | 0.4 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.1 | 0.1 | GO:0050720 | interleukin-1 beta biosynthetic process(GO:0050720) |
0.1 | 0.1 | GO:0061740 | protein targeting to lysosome involved in chaperone-mediated autophagy(GO:0061740) |
0.1 | 0.4 | GO:0035407 | histone H3-T11 phosphorylation(GO:0035407) |
0.1 | 0.1 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
0.1 | 0.2 | GO:0098507 | polynucleotide 5' dephosphorylation(GO:0098507) |
0.1 | 0.4 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.1 | 0.5 | GO:1990481 | mRNA pseudouridine synthesis(GO:1990481) |
0.1 | 0.5 | GO:0007144 | female meiosis I(GO:0007144) |
0.1 | 0.7 | GO:0070495 | regulation of thrombin receptor signaling pathway(GO:0070494) negative regulation of thrombin receptor signaling pathway(GO:0070495) |
0.1 | 0.3 | GO:2001034 | positive regulation of double-strand break repair via nonhomologous end joining(GO:2001034) |
0.1 | 0.2 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.1 | 0.1 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.1 | 0.5 | GO:0002155 | thyroid hormone mediated signaling pathway(GO:0002154) regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
0.1 | 0.4 | GO:0072709 | cellular response to sorbitol(GO:0072709) |
0.1 | 0.1 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
0.1 | 0.1 | GO:1902957 | negative regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902957) |
0.1 | 0.2 | GO:0015960 | diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
0.1 | 1.3 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.1 | 0.3 | GO:0061084 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
0.1 | 0.1 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.1 | 0.2 | GO:0031392 | regulation of prostaglandin biosynthetic process(GO:0031392) regulation of unsaturated fatty acid biosynthetic process(GO:2001279) |
0.1 | 0.2 | GO:0032707 | negative regulation of interleukin-23 production(GO:0032707) |
0.1 | 0.2 | GO:2000282 | regulation of cellular amino acid biosynthetic process(GO:2000282) |
0.1 | 0.2 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.1 | 1.1 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.1 | 0.3 | GO:0035377 | transepithelial water transport(GO:0035377) positive regulation of cyclic nucleotide-gated ion channel activity(GO:1902161) |
0.1 | 0.3 | GO:1990022 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
0.1 | 0.4 | GO:0060179 | male mating behavior(GO:0060179) |
0.1 | 0.1 | GO:0048539 | bone marrow development(GO:0048539) |
0.1 | 0.4 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.1 | 0.5 | GO:0071461 | cellular response to redox state(GO:0071461) |
0.1 | 0.1 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
0.1 | 0.8 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.1 | 1.1 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.1 | 0.3 | GO:0071684 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.1 | 0.3 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
0.1 | 0.5 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.1 | 0.3 | GO:0000354 | cis assembly of pre-catalytic spliceosome(GO:0000354) |
0.1 | 0.3 | GO:0021816 | lamellipodium assembly involved in ameboidal cell migration(GO:0003363) extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration(GO:0021816) |
0.1 | 0.2 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.1 | 0.7 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
0.1 | 0.3 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.1 | 0.4 | GO:0098746 | fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
0.1 | 0.3 | GO:0051083 | 'de novo' cotranslational protein folding(GO:0051083) |
0.1 | 3.5 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.1 | 0.3 | GO:0021849 | neuroblast division in subventricular zone(GO:0021849) |
0.1 | 0.6 | GO:0035965 | cardiolipin acyl-chain remodeling(GO:0035965) |
0.1 | 0.7 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.1 | 0.5 | GO:1903575 | cornified envelope assembly(GO:1903575) |
0.1 | 0.6 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.1 | 0.3 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.1 | 0.2 | GO:1901202 | negative regulation of extracellular matrix assembly(GO:1901202) |
0.1 | 0.3 | GO:0097460 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
0.1 | 0.5 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.1 | 0.3 | GO:1904478 | regulation of intestinal absorption(GO:1904478) |
0.1 | 0.1 | GO:0000963 | mitochondrial RNA processing(GO:0000963) |
0.1 | 0.2 | GO:0002759 | regulation of antimicrobial humoral response(GO:0002759) |
0.1 | 0.1 | GO:0072683 | T cell extravasation(GO:0072683) |
0.1 | 0.1 | GO:0071139 | resolution of recombination intermediates(GO:0071139) resolution of mitotic recombination intermediates(GO:0071140) |
0.1 | 0.3 | GO:0035669 | TRAM-dependent toll-like receptor signaling pathway(GO:0035668) TRAM-dependent toll-like receptor 4 signaling pathway(GO:0035669) |
0.1 | 0.4 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
0.1 | 0.5 | GO:0017085 | response to insecticide(GO:0017085) |
0.1 | 0.3 | GO:0019605 | butyrate metabolic process(GO:0019605) |
0.1 | 0.5 | GO:0060702 | negative regulation of ribonuclease activity(GO:0060701) negative regulation of endoribonuclease activity(GO:0060702) |
0.1 | 0.3 | GO:1904647 | response to rotenone(GO:1904647) |
0.1 | 0.3 | GO:1904117 | response to vasopressin(GO:1904116) cellular response to vasopressin(GO:1904117) |
0.1 | 0.1 | GO:0015671 | oxygen transport(GO:0015671) |
0.1 | 0.3 | GO:0080009 | mRNA methylation(GO:0080009) |
0.1 | 0.2 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.1 | 0.2 | GO:0023016 | signal transduction by trans-phosphorylation(GO:0023016) |
0.1 | 0.3 | GO:0006305 | DNA alkylation(GO:0006305) DNA methylation(GO:0006306) |
0.1 | 0.2 | GO:0044861 | protein transport into plasma membrane raft(GO:0044861) |
0.1 | 0.2 | GO:0010845 | positive regulation of reciprocal meiotic recombination(GO:0010845) |
0.1 | 0.1 | GO:0032489 | regulation of Cdc42 protein signal transduction(GO:0032489) |
0.1 | 0.2 | GO:0061091 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
0.1 | 0.3 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.1 | 0.4 | GO:0072092 | ureteric bud invasion(GO:0072092) |
0.1 | 0.9 | GO:0002829 | negative regulation of type 2 immune response(GO:0002829) |
0.1 | 0.3 | GO:1903045 | neural crest cell migration involved in sympathetic nervous system development(GO:1903045) |
0.1 | 0.3 | GO:2000434 | regulation of protein neddylation(GO:2000434) negative regulation of protein neddylation(GO:2000435) |
0.1 | 0.3 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.1 | 0.3 | GO:0051754 | meiotic sister chromatid cohesion, centromeric(GO:0051754) |
0.1 | 0.4 | GO:0045648 | positive regulation of myeloid cell differentiation(GO:0045639) positive regulation of erythrocyte differentiation(GO:0045648) |
0.1 | 0.1 | GO:2000329 | negative regulation of T-helper 17 cell lineage commitment(GO:2000329) |
0.1 | 0.2 | GO:0002913 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.1 | 0.3 | GO:0010636 | positive regulation of mitochondrial fusion(GO:0010636) |
0.1 | 0.4 | GO:0061767 | negative regulation of lung blood pressure(GO:0061767) |
0.1 | 0.3 | GO:0046092 | deoxycytidine metabolic process(GO:0046092) |
0.1 | 0.4 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.1 | 0.4 | GO:1902746 | regulation of lens fiber cell differentiation(GO:1902746) |
0.1 | 0.2 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
0.1 | 0.2 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.1 | 0.3 | GO:0009304 | tRNA transcription(GO:0009304) 5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
0.1 | 0.5 | GO:0001821 | histamine secretion(GO:0001821) |
0.1 | 0.1 | GO:0034372 | very-low-density lipoprotein particle remodeling(GO:0034372) |
0.1 | 0.1 | GO:0002717 | positive regulation of natural killer cell mediated immunity(GO:0002717) |
0.1 | 0.2 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
0.1 | 0.2 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
0.1 | 0.1 | GO:0023019 | signal transduction involved in regulation of gene expression(GO:0023019) |
0.1 | 0.2 | GO:0046878 | regulation of saliva secretion(GO:0046877) positive regulation of saliva secretion(GO:0046878) |
0.1 | 0.1 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.1 | 0.3 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.1 | 0.1 | GO:0032455 | nerve growth factor processing(GO:0032455) |
0.1 | 0.1 | GO:2000705 | dense core granule biogenesis(GO:0061110) regulation of dense core granule biogenesis(GO:2000705) |
0.1 | 0.4 | GO:2000661 | positive regulation of interleukin-1-mediated signaling pathway(GO:2000661) |
0.1 | 0.5 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.1 | 1.1 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
0.1 | 0.3 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.1 | 0.4 | GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
0.1 | 0.2 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.1 | 0.5 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.1 | 0.2 | GO:1904815 | negative regulation of protein localization to chromosome, telomeric region(GO:1904815) |
0.1 | 0.5 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.1 | 0.2 | GO:0045471 | response to ethanol(GO:0045471) |
0.1 | 0.1 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.1 | 0.1 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.1 | 0.6 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.1 | 0.1 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.1 | 0.3 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
0.1 | 0.2 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
0.1 | 0.1 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
0.1 | 0.2 | GO:0035408 | histone H3-T6 phosphorylation(GO:0035408) |
0.1 | 0.3 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
0.1 | 0.3 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.1 | 0.2 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.1 | 0.3 | GO:1903364 | positive regulation of cellular protein catabolic process(GO:1903364) |
0.1 | 0.2 | GO:0032972 | regulation of muscle filament sliding speed(GO:0032972) |
0.1 | 0.1 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.1 | 0.2 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
0.1 | 0.2 | GO:0071848 | regulation of fever generation by regulation of prostaglandin secretion(GO:0071810) positive regulation of fever generation by positive regulation of prostaglandin secretion(GO:0071812) positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling(GO:0071848) regulation of fever generation by prostaglandin secretion(GO:0100009) |
0.1 | 1.1 | GO:0016180 | snRNA processing(GO:0016180) |
0.1 | 0.1 | GO:2000295 | regulation of hydrogen peroxide catabolic process(GO:2000295) |
0.1 | 0.2 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.1 | 0.2 | GO:0071109 | superior temporal gyrus development(GO:0071109) |
0.1 | 0.1 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.1 | 0.1 | GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) branch elongation involved in mammary gland duct branching(GO:0060751) |
0.1 | 0.1 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.1 | 0.2 | GO:0060545 | positive regulation of necroptotic process(GO:0060545) |
0.1 | 0.2 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.1 | 0.1 | GO:0060913 | cardiac cell fate determination(GO:0060913) |
0.1 | 0.2 | GO:0090362 | positive regulation of platelet-derived growth factor production(GO:0090362) |
0.1 | 2.3 | GO:0022011 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
0.1 | 0.1 | GO:1903181 | regulation of dopamine biosynthetic process(GO:1903179) positive regulation of dopamine biosynthetic process(GO:1903181) |
0.1 | 0.2 | GO:0098972 | dendritic transport of mitochondrion(GO:0098939) anterograde dendritic transport of mitochondrion(GO:0098972) |
0.1 | 0.2 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.1 | 0.1 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.1 | 0.1 | GO:0000960 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.1 | 0.5 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.1 | 0.2 | GO:1903676 | regulation of cap-dependent translational initiation(GO:1903674) positive regulation of cap-dependent translational initiation(GO:1903676) |
0.1 | 0.1 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.1 | 1.1 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
0.1 | 0.2 | GO:0070843 | misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) |
0.1 | 0.3 | GO:0043335 | protein unfolding(GO:0043335) |
0.1 | 0.4 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.1 | 0.5 | GO:0014866 | skeletal myofibril assembly(GO:0014866) |
0.1 | 0.2 | GO:0070839 | divalent metal ion export(GO:0070839) |
0.1 | 0.2 | GO:0046080 | dUTP metabolic process(GO:0046080) dUTP catabolic process(GO:0046081) |
0.1 | 0.1 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.1 | 0.8 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.1 | 0.2 | GO:2000389 | regulation of neutrophil extravasation(GO:2000389) |
0.1 | 0.2 | GO:0006147 | guanine catabolic process(GO:0006147) |
0.1 | 0.2 | GO:0019285 | glycine betaine biosynthetic process from choline(GO:0019285) glycine betaine metabolic process(GO:0031455) glycine betaine biosynthetic process(GO:0031456) |
0.1 | 0.6 | GO:0010993 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
0.1 | 0.6 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.1 | 0.1 | GO:0050691 | regulation of defense response to virus by host(GO:0050691) |
0.1 | 0.8 | GO:0000492 | box C/D snoRNP assembly(GO:0000492) |
0.1 | 0.2 | GO:0002372 | myeloid dendritic cell cytokine production(GO:0002372) |
0.1 | 0.1 | GO:0015840 | urea transport(GO:0015840) urea transmembrane transport(GO:0071918) |
0.1 | 0.7 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.1 | 0.3 | GO:1990418 | response to insulin-like growth factor stimulus(GO:1990418) |
0.1 | 0.2 | GO:0019217 | regulation of fatty acid metabolic process(GO:0019217) |
0.1 | 0.3 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.1 | 1.4 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.1 | 0.9 | GO:0006071 | glycerol metabolic process(GO:0006071) |
0.1 | 0.1 | GO:0002005 | angiotensin catabolic process in blood(GO:0002005) |
0.1 | 0.1 | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) |
0.1 | 1.0 | GO:1901620 | regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901620) |
0.1 | 0.1 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
0.1 | 0.1 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.1 | 0.3 | GO:0030242 | pexophagy(GO:0030242) |
0.1 | 0.2 | GO:1903979 | negative regulation of microglial cell activation(GO:1903979) |
0.1 | 0.2 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
0.1 | 0.8 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.1 | 0.2 | GO:0051891 | positive regulation of cardioblast differentiation(GO:0051891) |
0.1 | 0.1 | GO:0060405 | regulation of penile erection(GO:0060405) |
0.0 | 0.2 | GO:2000691 | regulation of cardiac muscle cell myoblast differentiation(GO:2000690) negative regulation of cardiac muscle cell myoblast differentiation(GO:2000691) |
0.0 | 0.2 | GO:2000567 | memory T cell activation(GO:0035709) regulation of memory T cell activation(GO:2000567) positive regulation of memory T cell activation(GO:2000568) |
0.0 | 1.0 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.0 | 0.4 | GO:0060677 | ureteric bud elongation(GO:0060677) branch elongation involved in ureteric bud branching(GO:0060681) |
0.0 | 0.1 | GO:0002519 | natural killer cell tolerance induction(GO:0002519) regulation of tolerance induction dependent upon immune response(GO:0002652) negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) negative regulation of natural killer cell mediated immune response to tumor cell(GO:0002856) negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002859) |
0.0 | 0.0 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.0 | 0.1 | GO:0072156 | distal tubule morphogenesis(GO:0072156) |
0.0 | 0.2 | GO:0090076 | relaxation of skeletal muscle(GO:0090076) |
0.0 | 0.2 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.0 | 0.7 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.0 | 0.2 | GO:0035627 | ceramide transport(GO:0035627) |
0.0 | 0.7 | GO:0034982 | mitochondrial protein processing(GO:0034982) |
0.0 | 0.1 | GO:1904924 | negative regulation of mitophagy in response to mitochondrial depolarization(GO:1904924) |
0.0 | 0.3 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
0.0 | 0.1 | GO:2000307 | iron assimilation(GO:0033212) iron assimilation by chelation and transport(GO:0033214) tumor necrosis factor (ligand) superfamily member 11 production(GO:0072535) regulation of bone mineralization involved in bone maturation(GO:1900157) positive regulation of bone mineralization involved in bone maturation(GO:1900159) regulation of tumor necrosis factor (ligand) superfamily member 11 production(GO:2000307) negative regulation of tumor necrosis factor (ligand) superfamily member 11 production(GO:2000308) |
0.0 | 0.3 | GO:0015942 | formate metabolic process(GO:0015942) |
0.0 | 0.6 | GO:0014809 | regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
0.0 | 0.5 | GO:0009249 | protein lipoylation(GO:0009249) |
0.0 | 0.5 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.0 | 1.2 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
0.0 | 0.2 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.0 | 0.3 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.0 | 0.5 | GO:0036500 | ATF6-mediated unfolded protein response(GO:0036500) |
0.0 | 0.2 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.0 | 0.1 | GO:0019442 | tryptophan catabolic process to acetyl-CoA(GO:0019442) |
0.0 | 0.2 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.0 | 0.2 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.0 | 0.0 | GO:0001300 | chronological cell aging(GO:0001300) |
0.0 | 0.0 | GO:0072577 | endothelial cell apoptotic process(GO:0072577) |
0.0 | 0.8 | GO:0003351 | epithelial cilium movement(GO:0003351) |
0.0 | 0.9 | GO:0002438 | acute inflammatory response to antigenic stimulus(GO:0002438) |
0.0 | 0.1 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.0 | 0.1 | GO:0051389 | inactivation of MAPKK activity(GO:0051389) |
0.0 | 0.0 | GO:0010519 | negative regulation of phospholipase activity(GO:0010519) |
0.0 | 0.1 | GO:0030168 | platelet activation(GO:0030168) |
0.0 | 0.6 | GO:1990416 | cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
0.0 | 0.2 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.0 | 0.4 | GO:0097350 | neutrophil clearance(GO:0097350) |
0.0 | 0.1 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.0 | 0.2 | GO:0006121 | mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
0.0 | 0.7 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
0.0 | 0.3 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.0 | 0.2 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
0.0 | 0.1 | GO:0007057 | spindle assembly involved in female meiosis I(GO:0007057) |
0.0 | 0.1 | GO:2000687 | negative regulation of rubidium ion transport(GO:2000681) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
0.0 | 0.4 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
0.0 | 0.1 | GO:0061193 | sensory organ boundary specification(GO:0008052) formation of organ boundary(GO:0010160) taste bud development(GO:0061193) |
0.0 | 0.4 | GO:0072734 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
0.0 | 0.1 | GO:0007198 | adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) |
0.0 | 0.2 | GO:0035574 | histone H4-K20 demethylation(GO:0035574) |
0.0 | 0.4 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.0 | 0.0 | GO:0045604 | regulation of epidermal cell differentiation(GO:0045604) |
0.0 | 0.1 | GO:0060423 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) positive regulation of branching involved in lung morphogenesis(GO:0061047) |
0.0 | 0.0 | GO:0021648 | vestibulocochlear nerve morphogenesis(GO:0021648) |
0.0 | 0.0 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.0 | 0.4 | GO:0070129 | regulation of mitochondrial translation(GO:0070129) |
0.0 | 0.4 | GO:0006552 | leucine catabolic process(GO:0006552) |
0.0 | 0.4 | GO:0048296 | regulation of isotype switching to IgA isotypes(GO:0048296) positive regulation of isotype switching to IgA isotypes(GO:0048298) |
0.0 | 0.4 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.0 | 0.2 | GO:0061763 | multivesicular body-lysosome fusion(GO:0061763) |
0.0 | 0.1 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.0 | 0.4 | GO:0015677 | copper ion import(GO:0015677) |
0.0 | 0.2 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
0.0 | 0.0 | GO:1904872 | regulation of telomerase RNA localization to Cajal body(GO:1904872) |
0.0 | 0.8 | GO:0045116 | protein neddylation(GO:0045116) |
0.0 | 0.1 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.0 | 0.4 | GO:1900623 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
0.0 | 0.2 | GO:1904158 | axonemal central apparatus assembly(GO:1904158) |
0.0 | 0.5 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.0 | 0.3 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.0 | 0.3 | GO:0070236 | regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.0 | 0.6 | GO:0075713 | establishment of integrated proviral latency(GO:0075713) |
0.0 | 0.3 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.0 | 0.7 | GO:0006085 | acetyl-CoA biosynthetic process(GO:0006085) |
0.0 | 0.2 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
0.0 | 0.2 | GO:0036269 | swimming behavior(GO:0036269) |
0.0 | 0.4 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.0 | 0.1 | GO:0046469 | platelet activating factor metabolic process(GO:0046469) |
0.0 | 0.1 | GO:0060382 | regulation of DNA strand elongation(GO:0060382) |
0.0 | 0.7 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.0 | 0.1 | GO:0045077 | negative regulation of interferon-gamma biosynthetic process(GO:0045077) regulation of ovulation(GO:0060278) positive regulation of ovulation(GO:0060279) |
0.0 | 0.1 | GO:0060667 | fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow(GO:0035602) fibroblast growth factor receptor signaling pathway involved in hemopoiesis(GO:0035603) fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow(GO:0035604) fibroblast growth factor receptor signaling pathway involved in mammary gland specification(GO:0060595) mammary gland bud formation(GO:0060615) branch elongation involved in salivary gland morphogenesis(GO:0060667) mesenchymal cell differentiation involved in lung development(GO:0060915) |
0.0 | 0.2 | GO:1904977 | lymphatic endothelial cell migration(GO:1904977) |
0.0 | 0.0 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.0 | 0.2 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.0 | 0.2 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
0.0 | 0.1 | GO:0060371 | regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
0.0 | 0.2 | GO:0009447 | putrescine catabolic process(GO:0009447) |
0.0 | 0.1 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) positive regulation of guanylate cyclase activity(GO:0031284) |
0.0 | 0.2 | GO:0070459 | prolactin secretion(GO:0070459) |
0.0 | 0.5 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.0 | 0.2 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.0 | 0.0 | GO:0071554 | cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
0.0 | 0.2 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.0 | 0.8 | GO:1904754 | positive regulation of vascular associated smooth muscle cell migration(GO:1904754) |
0.0 | 0.1 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.0 | 0.0 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
0.0 | 0.0 | GO:1900449 | regulation of glutamate receptor signaling pathway(GO:1900449) |
0.0 | 0.0 | GO:0046337 | phosphatidylethanolamine metabolic process(GO:0046337) |
0.0 | 0.2 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.0 | 0.2 | GO:0051451 | myoblast migration(GO:0051451) |
0.0 | 0.4 | GO:0018406 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.0 | 0.1 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.0 | 0.1 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.0 | 0.1 | GO:0006427 | histidyl-tRNA aminoacylation(GO:0006427) |
0.0 | 0.2 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.0 | 0.7 | GO:0001502 | cartilage condensation(GO:0001502) |
0.0 | 0.0 | GO:0032661 | regulation of interleukin-18 production(GO:0032661) |
0.0 | 0.9 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
0.0 | 0.2 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.0 | 0.4 | GO:0035986 | senescence-associated heterochromatin focus assembly(GO:0035986) |
0.0 | 0.0 | GO:0019755 | one-carbon compound transport(GO:0019755) |
0.0 | 0.3 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.0 | 0.4 | GO:0016446 | somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.0 | 0.0 | GO:0021940 | regulation of cerebellar granule cell precursor proliferation(GO:0021936) positive regulation of cerebellar granule cell precursor proliferation(GO:0021940) |
0.0 | 0.1 | GO:0034285 | response to sucrose(GO:0009744) response to disaccharide(GO:0034285) |
0.0 | 0.2 | GO:0036512 | trimming of terminal mannose on B branch(GO:0036509) trimming of first mannose on A branch(GO:0036511) trimming of second mannose on A branch(GO:0036512) |
0.0 | 0.2 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.0 | 0.1 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
0.0 | 0.3 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.0 | 0.0 | GO:0051495 | positive regulation of cytoskeleton organization(GO:0051495) |
0.0 | 0.3 | GO:1902731 | negative regulation of chondrocyte proliferation(GO:1902731) |
0.0 | 0.0 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.0 | 0.4 | GO:0000012 | single strand break repair(GO:0000012) |
0.0 | 0.4 | GO:0035583 | sequestering of TGFbeta in extracellular matrix(GO:0035583) |
0.0 | 0.1 | GO:2000819 | regulation of nucleotide-excision repair(GO:2000819) |
0.0 | 0.2 | GO:0006027 | aminoglycan catabolic process(GO:0006026) glycosaminoglycan catabolic process(GO:0006027) |
0.0 | 0.3 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.0 | 0.1 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.0 | 0.3 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.0 | 0.1 | GO:0021553 | olfactory nerve development(GO:0021553) |
0.0 | 0.1 | GO:2000611 | pronephric field specification(GO:0039003) pattern specification involved in pronephros development(GO:0039017) thyroid-stimulating hormone secretion(GO:0070460) kidney field specification(GO:0072004) DCT cell differentiation(GO:0072069) metanephric DCT cell differentiation(GO:0072240) regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis(GO:0072304) negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis(GO:0072305) mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis(GO:0072309) mesenchymal cell apoptotic process involved in metanephros development(GO:1900200) apoptotic process involved in metanephric collecting duct development(GO:1900204) apoptotic process involved in metanephric nephron tubule development(GO:1900205) regulation of mesenchymal cell apoptotic process involved in metanephros development(GO:1900211) negative regulation of mesenchymal cell apoptotic process involved in metanephros development(GO:1900212) regulation of apoptotic process involved in metanephric collecting duct development(GO:1900214) negative regulation of apoptotic process involved in metanephric collecting duct development(GO:1900215) regulation of apoptotic process involved in metanephric nephron tubule development(GO:1900217) negative regulation of apoptotic process involved in metanephric nephron tubule development(GO:1900218) mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis(GO:1901147) regulation of metanephric DCT cell differentiation(GO:2000592) positive regulation of metanephric DCT cell differentiation(GO:2000594) positive regulation of thyroid hormone generation(GO:2000611) regulation of thyroid-stimulating hormone secretion(GO:2000612) |
0.0 | 0.1 | GO:0016256 | N-glycan processing to lysosome(GO:0016256) |
0.0 | 0.2 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.0 | 0.8 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.0 | 0.1 | GO:1900075 | regulation of neuromuscular synaptic transmission(GO:1900073) positive regulation of neuromuscular synaptic transmission(GO:1900075) |
0.0 | 0.3 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.0 | 0.2 | GO:0055014 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
0.0 | 0.1 | GO:0044727 | DNA demethylation of male pronucleus(GO:0044727) |
0.0 | 1.8 | GO:0006294 | nucleotide-excision repair, preincision complex assembly(GO:0006294) |
0.0 | 0.7 | GO:0015886 | heme transport(GO:0015886) |
0.0 | 0.1 | GO:0090344 | negative regulation of cell aging(GO:0090344) |
0.0 | 0.6 | GO:0021794 | thalamus development(GO:0021794) |
0.0 | 0.1 | GO:0045226 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.0 | 0.1 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
0.0 | 0.1 | GO:0048290 | isotype switching to IgA isotypes(GO:0048290) |
0.0 | 0.3 | GO:0017062 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.0 | 0.1 | GO:0050706 | regulation of interleukin-1 beta secretion(GO:0050706) positive regulation of interleukin-1 beta secretion(GO:0050718) |
0.0 | 0.0 | GO:0097695 | establishment of RNA localization to telomere(GO:0097694) establishment of macromolecular complex localization to telomere(GO:0097695) telomerase catalytic core complex assembly(GO:1904868) regulation of telomerase catalytic core complex assembly(GO:1904882) positive regulation of telomerase catalytic core complex assembly(GO:1904884) |
0.0 | 0.1 | GO:0071400 | carbamoyl phosphate metabolic process(GO:0070408) carbamoyl phosphate biosynthetic process(GO:0070409) cellular response to oleic acid(GO:0071400) response to ammonia(GO:1903717) cellular response to ammonia(GO:1903718) |
0.0 | 0.1 | GO:0036353 | histone H2A-K119 monoubiquitination(GO:0036353) |
0.0 | 0.0 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.0 | 0.3 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.0 | 0.0 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.0 | 0.0 | GO:0071352 | cellular response to interleukin-2(GO:0071352) |
0.0 | 0.1 | GO:1903524 | positive regulation of |